Pyrvinium Pamoate

CHEMBL1908377 Phase 4 Đã phê duyệt Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

1151.4 g/mol

LogP

—

Phase

4

Pyrvinium pamoate is the pamoate salt formulation of pyrvinium, an antiparasitic agent used for treatment of pinworm infections that also inhibits the Wnt/beta-catenin signaling pathway, making it of interest as an anticancer agent in pancreatic and other cancers. See pyrvinium for complete pharmacological details.

Khối lượng phân tử

1151,4000 g/mol

TPSA

145,00 Å²

Lĩnh vực điều trị

Pancreatic Cancer

Cơ chế tác dụng

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Cấu trúc 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)[O-])cc3ccccc23)c1O

InChI

InChI=1S/2C26H28N3.C23H16O6/c2*1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h2*6-18H,1-5H3;1-10,24-25H,11H2,(H,26,27)(H,28,29)/q2*+1;/p-2

Molecular Formula

C75H70N6O6

HBD / HBA

2 / 8

Liên kết có thể quay

12

Nguyên tử nặng

87

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Pyrvinium pamoate is the pamoate salt formulation of pyrvinium, an antiparasitic agent used for treatment of pinworm infections that also inhibits the Wnt/beta-catenin signaling pathway, making it of interest as an anticancer agent in pancreatic and other cancers. See pyrvinium for complete pharmacological details.

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Yes, Pyrvinium Pamoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908377. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54680693. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Bạn đang tìm kiếm thông tin thân thiện với bệnh nhân?

Pyrvinium Pamoate trên PillFYI

Cấu trúc

Dữ liệu nhanh

Công thức: C75H70N6O6

Liên kết ngoài

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Pyrvinium Pamoate

Lĩnh vực điều trị

Cơ chế tác dụng

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

Cite this structure

Embed this structure

No targets recorded

No interactions recorded

No side effects recorded

Câu hỏi thường gặp

References & Data Sources

Embed This Widget